Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas Infections | 2 | 2016 | 118 | 0.460 |
Why?
|
| Rib Fractures | 1 | 2015 | 27 | 0.460 |
Why?
|
| Cartilage | 1 | 2015 | 51 | 0.460 |
Why?
|
| Thoracic Wall | 1 | 2015 | 40 | 0.450 |
Why?
|
| Fracture Fixation, Internal | 1 | 2015 | 83 | 0.450 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2015 | 109 | 0.410 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2016 | 176 | 0.370 |
Why?
|
| Pneumonia, Bacterial | 1 | 2012 | 81 | 0.360 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 140 | 0.350 |
Why?
|
| Lung Injury | 1 | 2012 | 121 | 0.340 |
Why?
|
| Heart-Assist Devices | 7 | 2009 | 1089 | 0.300 |
Why?
|
| Dextrocardia | 1 | 2005 | 9 | 0.230 |
Why?
|
| Heart Failure | 5 | 2009 | 2389 | 0.190 |
Why?
|
| Wounds and Injuries | 2 | 2015 | 392 | 0.180 |
Why?
|
| Multiple Trauma | 1 | 2016 | 63 | 0.120 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2015 | 133 | 0.110 |
Why?
|
| Flow Cytometry | 2 | 2015 | 806 | 0.100 |
Why?
|
| Multiple Organ Failure | 1 | 2015 | 144 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 220 | 0.100 |
Why?
|
| Clinical Protocols | 1 | 2014 | 242 | 0.100 |
Why?
|
| Monocytes | 1 | 2015 | 345 | 0.100 |
Why?
|
| Pneumonia | 1 | 2016 | 335 | 0.100 |
Why?
|
| Heart Transplantation | 4 | 2007 | 862 | 0.100 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2012 | 33 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2014 | 307 | 0.100 |
Why?
|
| Enteral Nutrition | 1 | 2014 | 269 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 55 | 0.090 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2012 | 149 | 0.090 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 311 | 0.090 |
Why?
|
| Intensive Care Units | 1 | 2014 | 526 | 0.080 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 292 | 0.080 |
Why?
|
| Myocardium | 2 | 2005 | 892 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2012 | 880 | 0.080 |
Why?
|
| Critical Care | 1 | 2014 | 689 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2014 | 697 | 0.070 |
Why?
|
| Middle Aged | 8 | 2015 | 28801 | 0.070 |
Why?
|
| Male | 11 | 2016 | 64856 | 0.070 |
Why?
|
| Respiration, Artificial | 2 | 2014 | 497 | 0.070 |
Why?
|
| Diet | 1 | 2014 | 1170 | 0.070 |
Why?
|
| Endomyocardial Fibrosis | 1 | 2006 | 3 | 0.070 |
Why?
|
| Proteoglycans | 1 | 2006 | 91 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 1758 | 0.060 |
Why?
|
| Early Ambulation | 1 | 2006 | 9 | 0.060 |
Why?
|
| Aged | 6 | 2015 | 21301 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2006 | 157 | 0.060 |
Why?
|
| Ventricular Remodeling | 1 | 2006 | 165 | 0.060 |
Why?
|
| Equipment Failure | 1 | 2005 | 134 | 0.060 |
Why?
|
| Heart Ventricles | 2 | 2006 | 749 | 0.060 |
Why?
|
| Antibody Formation | 1 | 2005 | 274 | 0.060 |
Why?
|
| Hypertension, Pulmonary | 1 | 2009 | 463 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2015 | 12874 | 0.060 |
Why?
|
| Brain Death | 1 | 2005 | 73 | 0.050 |
Why?
|
| Cardiac Output, Low | 1 | 2004 | 62 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2006 | 475 | 0.050 |
Why?
|
| Mast Cells | 1 | 2004 | 68 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2006 | 880 | 0.050 |
Why?
|
| Obesity | 1 | 2015 | 2407 | 0.050 |
Why?
|
| Cell Communication | 1 | 2004 | 187 | 0.050 |
Why?
|
| Ventricular Function | 1 | 2003 | 88 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2005 | 560 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2003 | 338 | 0.040 |
Why?
|
| Comorbidity | 1 | 2005 | 1601 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2003 | 526 | 0.040 |
Why?
|
| Interleukin-6 | 2 | 2016 | 435 | 0.040 |
Why?
|
| Humans | 12 | 2015 | 131987 | 0.040 |
Why?
|
| Mice | 2 | 2016 | 18562 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2016 | 666 | 0.040 |
Why?
|
| Cytokines | 1 | 2005 | 1367 | 0.040 |
Why?
|
| Liver Transplantation | 1 | 2007 | 1102 | 0.040 |
Why?
|
| Kidney | 1 | 2005 | 1335 | 0.030 |
Why?
|
| Lung | 1 | 2005 | 1551 | 0.030 |
Why?
|
| Animals | 3 | 2016 | 35053 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2015 | 17298 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2016 | 188 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2015 | 93 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2015 | 229 | 0.030 |
Why?
|
| Medical Audit | 1 | 2014 | 102 | 0.030 |
Why?
|
| Standard of Care | 1 | 2014 | 135 | 0.030 |
Why?
|
| Adult | 5 | 2015 | 31549 | 0.030 |
Why?
|
| Dietary Proteins | 1 | 2014 | 252 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2007 | 1538 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2014 | 326 | 0.020 |
Why?
|
| Energy Intake | 1 | 2014 | 516 | 0.020 |
Why?
|
| Female | 7 | 2015 | 70633 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2006 | 3060 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2006 | 2709 | 0.020 |
Why?
|
| Adolescent | 3 | 2015 | 20508 | 0.020 |
Why?
|
| Decorin | 1 | 2006 | 8 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 4755 | 0.020 |
Why?
|
| Polyethylene Terephthalates | 1 | 2005 | 30 | 0.020 |
Why?
|
| Physical Therapy Modalities | 1 | 2006 | 57 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 329 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2009 | 838 | 0.010 |
Why?
|
| Collagen | 1 | 2006 | 308 | 0.010 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2005 | 43 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2005 | 123 | 0.010 |
Why?
|
| HSP47 Heat-Shock Proteins | 1 | 2004 | 4 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2005 | 136 | 0.010 |
Why?
|
| Survivors | 1 | 2007 | 356 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2005 | 416 | 0.010 |
Why?
|
| Equipment Design | 1 | 2005 | 604 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2004 | 239 | 0.010 |
Why?
|
| Cell Separation | 1 | 2004 | 227 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 7091 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2006 | 454 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2004 | 191 | 0.010 |
Why?
|
| Risk Factors | 2 | 2009 | 10829 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 1562 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2005 | 510 | 0.010 |
Why?
|
| Swine | 1 | 2005 | 1186 | 0.010 |
Why?
|
| Critical Illness | 1 | 2006 | 626 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 9929 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2004 | 532 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2003 | 370 | 0.010 |
Why?
|
| Registries | 1 | 2005 | 1580 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 2483 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 1875 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 6406 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2007 | 14818 | 0.010 |
Why?
|
| United States | 1 | 2003 | 11607 | 0.000 |
Why?
|
| Child | 1 | 2007 | 25772 | 0.000 |
Why?
|